[AACR] A phase 1 study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer |
Reward30points
Best Answer
2024-2-2
|
| |
post
reply
points
1320
50
Abstract 4237: Social isolation induces gut dysbiosis, mitochondrial metabolic dysfunction, and infiltration of tumor immunosuppressive cells: Do they explain enhanced mammary tumorigenesis
20
An Antitumor T-cell Response Was Induced by Engineered Commensal Bacteria
30
Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions
30
Abstract LB066: Machine learning algorithm for drug discovery targeting new co-transcription factors of HIF1A
30
Novel WRN Helicase Inhibitors Selectively Target Microsatellite Unstable Cancer Cells.
